Q1 2026 Holdings
Filed 2026-05-15 | 20 holdings | $360.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Erasca Inc(ERAS) | COM | 29479A108 | $56.4M | 3,485,971 | 15.7% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $51.2M | 4,056,379 | 14.2% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $39.4M | 1,029,298 | 10.9% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $25.9M | 5,869,091 | 7.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $23.1M | 580,945 | 6.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $22.5M | 797,600 | 6.3% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $19.3M | 950,011 | 5.4% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $18.8M | 606,660 | 5.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $15.8M | 497,270 | 4.4% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $15.2M | 2,353,304 | 4.2% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $13.5M | 1,050,000 | 3.8% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $11.3M | 387,500 | 3.1% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $9.2M | 3,947,913 | 2.6% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $8.1M | 572,665 | 2.2% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.1M | 1,369,782 | 2.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $6.3M | 738,972 | 1.7% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.1M | 3,057,325 | 1.7% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $6.0M | 9,681,763 | 1.7% |
| Rallybio Corp(RLYB) | COM | 75120L209 | $2.6M | 291,788 | 0.7% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.5M | 476,200 | 0.7% |